Halt! —

After biosafety lapses, US halts funding for work modifying virus targets

Helping a bird flu virus infect mammals is off the table pending review.

Today, the White House announced a pause in a specific type of research on viruses. Rather than being a response to the recent Ebola infections, this dates back to events that began in 2011. Back then, researchers who were studying the bird flu put it through a series of lab procedures that ended with a flu virus that could readily infect mammals. Some members of the scientific community considered this work irresponsible, as the resulting virus could, again, potentially infect humans.

Similar research and a debate over its value and threat have continued. Now, however, the Obama administration decided to put it on hold. Prompted by several recent biosafety lapses (including the discovery of old smallpox samples at the National Institutes of Health), the government will temporarily stop funding for these projects. During the pause, the government will organize a "deliberative process" that will consider the value of the research and the appropriate safety precautions that will need to be followed if it's done. The review will be run by a combination of the National Science Advisory Board for Biosecurity and the National Academies of Science.

The funding pause will apply to any projects that can allow viruses like the flu, MERS, and SARS to either add mammals to the list of species they can infect, or to increase their virulence following infection. The government also hopes that any lab pursuing this research using private funding will voluntarily join in the pause. Researchers who are simply studying naturally occurring viruses without modifying them will not be affected by this pause.

The government's announcement can be read here.

Channel Ars Technica